August 23, 2022

Plunkett Research, Ltd., a Houston-based market research firm, has published a complete, new report on the Biotech, Pharmaceuticals & Genetics Industry.  (Plunkett’s Biotech, Pharmaceuticals & Genetics Industry Almanac 2023,  It contains hundreds of pages of vital insights, including forecasts, market sizing, technologies analysis, trends analysis and statistical tables, as well as data on top global companies.

Key Findings:

A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry.  Gain vital insights that can help shape strategy for business development, product development and investments.

Key Features:

  • Business trends analysis
  • In-depth industry overview
  • Technology trends analysis
  • Forecasts
  • Spending, investment, and consumption discussions
  • In-depth industry statistics and metrics
  • Industry employment numbers

Additional Key Features Include:

Industry Glossary

Industry Contacts list, including Professional Societies and Industry Associations

Profiles of industry-leading companies

  • U.S. and Global Firms
  • Publicly held, Private and Subsidiaries
  • Executive Contacts
  • Revenues
  • For Public Companies: Detailed Financial Summaries

Pages: 498

Statistical Tables Provided: 8

Companies Profiled: 400

Geographic Focus: Global

Price: $399.99

Key Questions Answered Include:

  • How is the industry evolving?
  • How is the industry being shaped by new technologies?
  • How is demand growing in emerging markets and mature economies?
  • What is the size of the market now and in the future?
  • What are the financial results of the leading companies?
  • What are the names and titles of top executives?
  • What are the top companies and what are their revenues?

This feature-rich report covers competitive intelligence, market research and business analysis—everything you need to know about the Biotech, Pharmaceuticals & Genetics Industry.

Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry

  1. The State of the Biotechnology Industry Today
  2. The Coronavirus’ Effect on the Biotech, Pharmaceuticals & Genetics Industry
  3. A Short History of Biotechnology
  4. Fast Track Drugs Come to Market in the U.S. with FDA Cooperation
  5. Ethanol Production Soared, But U.S. Federal Subsidy Expires
  6. Cellulosic Ethanol Makes Slow Commercial Progress
  7. Major Drug Companies Acquire or Partner With Smaller Biotech Firms
  8. Pharmaceutical R&D Improves with Artificial Intelligence (AI)
  9. From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
  10. Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
  11. Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
  12. Vaccines & Viruses as Therapies/mRNA Shows Great Promise
  13. Massive R&D Investment Required for Development and Approval of New Drug/Drug Prices Soar
  14. Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues
  15. America Pays Higher Prices for Drugs Than Other Nations/U.S. Government Launches Drug Price Negotiation and Control Powers for Medicare
  16. Biotech and Orphan Drugs Create New Revenues for Drug Firms
  17. Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/ Competition Will Be Fierce
  18. Market for CBD Is on the Rise
  19. Stem Cells and 3-D Printing—A New Era of Tissue Replacement Takes Shape
  20. Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High
  21. Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation
  22. Plant-Based Meat Substitutes Developed
  23. Selective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds
  24. Immunotherapy and CAR-T Create Exciting New Approach to Fighting Cancers
  25. Technology Discussion—Genes and DNA
  26. Technology Discussion—Proteins and Proteomics
  27. Technology Discussion—DNA Chips
  28. Technology Discussion—SNPs (“Snips”)
  29. Technology Discussion—Synthetic Biology
  30. Technology Discussion—Recombinant DNA
  31. Technology Discussion—Polymerase Chain Reaction (PCR)

Biotech, Pharmaceuticals & Genetics Industry Statistics

  1. Biotech Industry Statistics and Market Size Overview
  2. The U.S. Drug Discovery & Approval Process
  3. U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2021
  4. Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2021
  5. Federal R&D & R&D Plant Funding for Basic Research, U.S.: Fiscal Years 2021-2023
  6. U.S. Exports & Imports of Pharmaceutical Products: 2016-2021
  7. Prescription Drug Expenditures, U.S.: Selected Years, 2014-2030
  8. NSF Budget by Appropriation (Dollars in Millions), Fiscal Years 2021-2023